Radcliffe Capital Management, L.P. - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 16 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$27,000
-66.7%
38,927
-30.1%
0.00%
-50.0%
Q2 2022$81,000
-85.6%
55,6920.0%0.00%
-84.6%
Q1 2022$562,000
-11.1%
55,692
-31.2%
0.01%
-23.5%
Q4 2021$632,00080,8970.02%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
LMR Partners LLP 358,349$520,0000.01%
Shaolin Capital Management LLC 823,999$156,0000.00%
Yakira Capital Management, Inc. 108,485$17,0000.00%
Radcliffe Capital Management, L.P. 55,692$81,0000.00%
EQUITEC PROPRIETARY MARKETS, LLC 45,000$7,0000.00%
MARSHALL WACE, LLP 285,000$413,0000.00%
MORGAN STANLEY 148,939$22,0000.00%
Walleye Trading LLC 15,505$2,0000.00%
Citadel Advisors 18,711$3,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,944$2,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders